Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Hartung

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Bayesian Data Assimilation to Support Informed Decision Making in Individualized ChemotherapyCorinna Maier, Niklas Hartung, Jana de Wiljes, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncologyCorinna Maier, Niklas Hartung, Charlotte Kloft, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2020
Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient FactorsFrancis W Ojara, Andrea Henrich, Nicolas Frances, et al.
Clinical Endocrinology|March 15, 2019
The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosingJohanna Melin, Niklas Hartung, Zinnia P Parra-Guillen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2020
Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal HyperplasiaJohanna Melin, Zinnia P Parra-Guillen, Robin Michelet, et al.
Clinical Pharmacokinetics|August 2, 2017
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy AdultsJohanna Melin, Zinnia P Parra-Guillen, Niklas Hartung, et al.
Cancer Research|September 14, 2014
Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing miceNiklas Hartung, Séverine Mollard, Dominique Barbolosi, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 14, 2023
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patientsFrancis Williams Ojara, Andrea Henrich, Nicolas Frances, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 26, 2025
Model-informed exploration of the boundaries of safe aluminium exposure from allergen immunotherapy in childrenKarin Weisser, Gaby Wangorsch, Niklas Hartung, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 7, 2020
Bayesian Data Assimilation to Support Informed Decision Making in Individualized ChemotherapyCorinna Maier, Niklas Hartung, Jana de Wiljes, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Reinforcement learning and Bayesian data assimilation for model-informed precision dosing in oncologyCorinna Maier, Niklas Hartung, Charlotte Kloft, et al.
Vaccines|April 27, 2026
Predicting Human Aluminium Exposure from Vaccinations Using a Physiologically-Based Toxicokinetic ModelKarin Weisser, Niklas Hartung, Gaby Wangorsch, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2020
Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient FactorsFrancis W Ojara, Andrea Henrich, Nicolas Frances, et al.
Clinical Endocrinology|March 15, 2019
The circadian rhythm of corticosteroid-binding globulin has little impact on cortisol exposure after hydrocortisone dosingJohanna Melin, Niklas Hartung, Zinnia P Parra-Guillen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2020
Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal HyperplasiaJohanna Melin, Zinnia P Parra-Guillen, Robin Michelet, et al.
Clinical Pharmacokinetics|August 2, 2017
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy AdultsJohanna Melin, Zinnia P Parra-Guillen, Niklas Hartung, et al.
Cancer Research|September 14, 2014
Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing miceNiklas Hartung, Séverine Mollard, Dominique Barbolosi, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 14, 2023
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patientsFrancis Williams Ojara, Andrea Henrich, Nicolas Frances, et al.
Pageof 3